This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of more complex pharmaceutical agents. Its structure, featuring a fluorinated piperidine ring, makes it valuable for the development of drugs targeting the central nervous system, as fluorine atoms can enhance binding affinity and metabolic stability. The benzyloxycarbonyl (Cbz) protecting group allows for selective deprotection during multi-step synthetic processes, enabling the construction of diverse drug candidates. It is particularly relevant in the preparation of compounds with potential applications in treating neurological disorders, such as Alzheimer's disease or Parkinson's disease, due to its ability to modulate receptor activity in the brain. Additionally, its chiral centers are crucial for creating enantiomerically pure substances, which are often required for effective and safe therapeutic agents.